BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 28, 2017
View Archived Issues
Regenxbio initiates phase I trial of gene therapy RGX-314 for wet AMD
Read More
Phase II trial of XEN-801 for acne does not meet efficacy endpoints
Read More
BARDA elects not to exercise options for AEOL-10150 development for ARS and DEARE
Read More
Xeljanz approved in Europe
Read More
AbbVie begins first-in-human trial of ABBV-621
Read More
Dacomitinib shows efficacy against penile squamous cell carcinoma
Read More
Levosimendan does not result in lower 30-day mortality in high risk cardiac surgery patients
Read More
KPR-2579, a novel TRPM8 antagonist for the potential treatment of bladder hypersensitivity
Read More
Erytech and Fox Chase to advance preclinical development of erymethionase for homocystinuria
Read More
Initiation of phase II trial of LN-145 in patients with squamous cell carcinoma of the head and neck
Read More
Epicentre presents phase III efficacy and safety results for oral BRV-PV rotavirus vaccine
Read More
Matinas reports topline phase I data on MAT-2501
Read More
Synergy submits supplemental NDA for Trulance in IBS-C
Read More
Numab and Ono Pharmaceutical enter immuno-oncology research and option agreement
Read More
Oncology Venture to evaluate Eisai drug for potential in-licensing
Read More
Amryt initiates phase III trial of AP-101 for epidermolysis bullosa
Read More
FDA approves Zejula for the maintenance treatment of women with recurrent ovarian cancer
Read More
ImMAGE Biotherapeutics advances immunotherapy for triple-negative breast cancer
Read More
Infectex reports results from phase IIb/III trial of SQ-109 for multidrug-resistant pulmonary TB
Read More
Sumitomo Dainippon Pharma presents Nav1.7 channel blockers
Read More
F. Hoffmann-La Roche AG patents gamma-secretase inhibitors
Read More
FDA grants priority review to Ryanodex NDA to treat exertional heat stroke
Read More
Genentech and F. Hoffmann-La Roche AG divulge PI3Kalpha inhibitors
Read More
European Commission gives conditional approval to DuPont and Dow Chemical Company's merger of equals
Read More
Vaximm updates on lead compound VXM-01 at BIO-Europe Spring
Read More
Foamix reports phase III topline results for FMX-101 in moderate to severe acne
Read More